drugset / Trial / NCT03482440

Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia

NCT03482440

Phase 0 Completed 24 enrolled University of Iowa Penn State University · collab
RandomizedCrossoverTriple-blindBasic science

Summary

Women who develop preeclampsia during pregnancy are more likely to develop cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs is unclear but may be related to blood vessel damage and increased inflammation that occurs during the preeclamptic pregnancy and persists postpartum. The purpose of this investigation is to 1) determine the mechanisms contributing to this lasting blood vessel damage and chronic inflammation, and to 2) identify factors (both physiological and pharmacological) that mitigate these negative effects in order to inform better clinical management of cardiovascular disease risk in women who have had preeclampsia.

Timeline

Start
2018-08-26
Primary completion
2019-07-11
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Salsalate Small molecule 1500 mg Oral

Indications